Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Concert Pharmaceuticals Inc.
CNCE
$
11.1
0.77%
Sun November 8th, 2020
08:17
Earnings
Analysis
Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q3 2020 Results - Earnings Call Transcript
Seeking Alpha
Fri November 6th, 2020
21:01
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Earnings
Analysis
Concert Pharmaceuticals, Inc. (CNCE) Q3 2020 Earnings Call Transcript
The Motley Fool
Thu October 1st, 2020
11:42
Analysis
Molina Acquires Affinity, And Other News: The Good, Bad And Ugly Of Biopharma
Seeking Alpha
Sun August 9th, 2020
17:21
Earnings
Analysis
Concert Pharmaceuticals, Inc. (CNCE) CEO Roger Tung on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha
Thu August 6th, 2020
18:06
Analysis
Concert Pharmaceuticals (CNCE) Investor Presentation - Slideshow
Seeking Alpha
17:31
Earnings
Analysis
Concert Pharmaceuticals, Inc. (CNCE) Q2 2020 Earnings Call Transcript
The Motley Fool
15:05
Analysis
Concert Pharmaceuticals (CNCE) Reports Q2 Loss, Tops Revenue Estimates
Zacks
Thu July 30th, 2020
16:33
Earnings
Analysis
Will Concert Pharmaceuticals (CNCE) Report Negative Q2 Earnings? What You Should Know
Zacks
Tue June 30th, 2020
16:00
Rating
Analysis
Concert (CNCE) Upgraded to Buy: Here's Why
Zacks
15:30
Analysis
Is Concert Pharmaceuticals (CNCE) Stock Outpacing Its Medical Peers This Year?
Zacks
